Literature DB >> 12904867

[New understanding of the immunopathogenesis of multiple sclerosis].

B Rosche1, B Kieseier, H-P Hartung, B Hemmer.   

Abstract

Multiple sclerosis is a chronic inflammatory and demyelinating disease of the central nervous system. Although the immune system seems to play an important role in its pathogenesis, target antigens are still uncertain and pathways leading to tissue destruction have not been fully elucidated. Recent studies have significantly contributed to better understanding of the disease process and broadened our view on possible scenarios of disease initiation and progression. Here, we review the role of the immune system in the manifestation and evolution of MS and discuss different pathogenetic concepts. We conclude with an outlook on future strategies for identifying the cause of MS.

Entities:  

Mesh:

Year:  2003        PMID: 12904867     DOI: 10.1007/s00115-003-1534-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  126 in total

1.  APOE genotype is a major predictor of long-term progression of disability in MS.

Authors:  J Chapman; S Vinokurov; A Achiron; D M Karussis; K Mitosek-Szewczyk; M Birnbaum; D M Michaelson; A D Korczyn
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

2.  Immunopathology of secondary-progressive multiple sclerosis.

Authors:  J W Prineas; E E Kwon; E S Cho; L R Sharer; M H Barnett; E L Oleszak; B Hoffman; B P Morgan
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

3.  Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes.

Authors:  I Medana; M A Martinic; H Wekerle; H Neumann
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

Authors:  Paolo A Muraro; Klaus-Peter Wandinger; Bibiana Bielekova; Bruno Gran; Adriana Marques; Ursula Utz; Henry F McFarland; Steve Jacobson; Roland Martin
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

Review 5.  Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis.

Authors:  Peter Rieckmann; Mathias Mäurer
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

6.  Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis.

Authors:  S Cepok; M Jacobsen; S Schock; B Omer; S Jaekel; I Böddeker; W H Oertel; N Sommer; B Hemmer
Journal:  Brain       Date:  2001-11       Impact factor: 13.501

7.  BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

Authors:  Christine Stadelmann; Martin Kerschensteiner; Thomas Misgeld; Wolfgang Brück; Reinhard Hohlfeld; Hans Lassmann
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

8.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 9.  Axonal damage: a key predictor of outcome in human CNS diseases.

Authors:  I M Medana; M M Esiri
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

10.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.